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Abstract 
Motivation: Recent progress in m7G RNA methylation studies has focused on its internal (rather than capped) 
presence within mRNAs. Tens of thousands of internal mRNA m7G sites have been identified within mammalian 
transcriptomes, and a single resource to best share, annotate and analyze the massive m7G data generated 
recently is sorely needed. 
Results: We report here m7GHub, a comprehensive online platform for deciphering the location, regulation and 
pathogenesis of internal mRNA N7-methylguanosine. The m7GHub consists of four main components, includ-
ing: the first internal mRNA m7G database containing 44,058 experimentally-validated internal mRNA m7G sites, 
a sequence-based high-accuracy predictor, the first web server for assessing the impact of mutations on m7G 
status, and the first database recording 1,218 disease-associated genetic mutations that may function through 
regulation of m7G methylation. Together, m7GHub will serve as a useful resource for research on internal 
mRNA m7G modification. 
Availability: m7GHub is freely accessible online at: www.xjtlu.edu.cn/biologicalsciences/m7ghub.  
Contact: kunqi.chen@liverpool.ac.uk (KC) 
Supplementary information: Supplementary data are available at Bioinformatics online. 
 
 
1 Introduction  
Over 150 different RNA modifications have been identified in all three 
kingdoms of life, playing important roles in various cellular processes 
(Jaffrey, 2014; Zaccara, et al., 2019). Among them, N7-methylguanosine 
(m7G), the most ubiquitous RNA cap modification, is added to the 5’ cap 
co-transcriptionally during the initial phases of transcription and before 
other RNA processing events (Cowling, 2009). As a positively charged 
RNA modification, m7G capping plays significant roles in gene expres-
sion, protein synthesis, and transcript stabilization (Furuichi, et al., 
1977). It has been found that almost every phase of the life cycle of 
mRNA can be regulated by m7G cap modification, including transcrip-
tion (Pei and Shuman, 2002), mRNA splicing (Konarska, et al., 1984), 
nuclear export (Lewis and Izaurralde, 1997), and translation 
(Muthukrishnan, et al., 1975). The m7G RNA modification was also 
found in tRNA (Guy and Phizicky, 2014) and rRNA (Sloan, et al., 2017), 
where its presence has been associated with various diseases. For exam-
ple, mutations in the METTL1-WDR4 may cause a distinct form of 
microcephalic primordial dwarfism (Shaheen, et al., 2015). 
Thanks to the advances of high-throughput sequencing approaches 
developed for transcriptome-wide mapping of internal m7G modification 
(Chu, et al., 2018; Enroth, et al., 2019; Malbec, et al., 2019; Marchand, 
et al., 2018; Zhang, et al., 2019), recent studies confirmed the wide-
spread internal existence of m7G RNA modification on mRNAs, and 
revealed its conservation (Malbec, et al., 2019), regulation and dynamics 
(Zhang, et al., 2019) as well as its role in translation control. Zhang et al. 
invented the m7G-MeRIP-Seq and m7G-Seq techniques based on anti-
body immunoprecipitation and termination of reverse transcription, 
respectively (Zhang, et al., 2019). While m7G-MeRIP-Seq (Zhang, et al., 
2019) provides only limited resolution (~100bp), m7G-Seq (Zhang, et al., 
2019) achieved base-resolution in the detection of internal mRNA m7G 
sites by taking advantage of the misincorporation at m7G sites during 
reverse transcription. In addition, an alternative approach m7G-miCLIP-
seq (Malbec, et al., 2019) was also developed by combining anti-m7G 
antibody immunoprecipitation enrichment with ultraviolet (UV) cross-
linking. It provided an improved resolution (~30bp) than the convention-
al MeRIP-Seq method, and its resolution may be further narrowed down 
to base-resolution if combined with motif analysis.  
Experimental methods are usually effective but still costly and labori-
ous. To ensure that the massive data related to internal mRNA m7G 
methylation generated from high-throughput experiments are properly 
shared, annotated and taken advantage of, it is often beneficial to devel-
op complementary bioinformatics solutions. To date, many in silico 
efforts have been made to support the study of the epitranscriptome or 
RNA epigenetics (Chen, et al., 2017; Chen, et al., 2019). For example, 
B.Song et al. 
the experimentally validated m6A and other RNA modification sites in 
different species were collected in RMBase and MetDB (Liu, et al., 
2017; Xuan, et al., 2017) along with various functional annotations such 
as the splicing sites, microRNA targets and RNA protein binding sites. 
The RNA modification pathways can be queried from MODOMICS 
(Boccaletto, et al., 2017). Dedicated software tools and pipelines were 
developed for high-throughput sequencing data profiling various RNA 
modification marks (Cui, et al., 2016; Hauenschild, et al., 2015; Meng, et 
al., 2013; Rieder, et al., 2016; Schmidt, et al., 2019; Zhang, et al., 2019), 
and machine learning approaches such as iRNA-Methyl (Chen, et al., 
2015), iRNA-m7G (Chen, et al., 2019), BERMP (Huang, et al., 2018), 
SRAMP (Zhou, et al., 2016), DeepPromise (Chen, et al., 2019), 
Gene2Vec (Zou, et al., 2018) and WHISTLE (Chen, et al., 2019) were 
designed for accurate prediction of RNA modification sites. Enzyme-
specific RNA modification site predictions were made possible for PSI 
(He, et al., 2018) and m6A (Song, et al., 2019). Annotations related to 
RNA modifications may be obtained with RNAmod (Liu and Gregory, 
2019), RCAS (Uyar, et al., 2017) and RNA framework (Incarnato, et al., 
2018). Meanwhile, the disease and functional association of m6A RNA 
modification was revealed by m6AVar (Zheng, et al., 2017), m6ASNP 
(Jiang, et al., 2018), m6Acomet (Wu, et al., 2019), Deepm6A (Zhang, et 
al., 2019), DRUM (Tang, et al., 2019) and FunDMDeep-m6A (Zhang, et 
al., 2019) via disease-associated genetic variants or gene regulatory 
network and enrichment analysis. However, to the best of our 
knowledge, bioinformatics efforts for internal m7G RNA modification 
are still scarce. None of the existing bioinformatics databases collected 
the internal mRNA m7G sites, and their disease association has not been 
systematically inferred.  
We present here m7GHub, a centralized online platform for decipher-
ing the location, regulation and pathogenesis of internal mRNA m7G 
RNA methylation. The m7GHub consists of the following four major 
components:  
1) m7GDB: a database for experimentally validated internal mRNA 
m7G sites annotated with the post-transcriptional regulations poten-
tially affected. 
2) m7GFinder: a web server for high-accuracy prediction of putative 
internal mRNA m7G sites from DNA sequences or human genome 
coordinates. 
3) m7GSNPer: a web server for assessing the epitranscriptome im-
pact of genetic mutations on internal m7G RNA methylation. 
4) m7GDiseaseDB: a database for the disease-associated genetic 
variants that may lead to the gain or loss of an internal m7G site, 
with implications for disease pathogenesis involving m7G RNA 
methylation. 
Together, m7GHub serves as a useful online resource for the studies 
of internal mRNA m7G modification. 
2 Materials and Methods 
Internal mRNA m7G sites collected in m7GDB (m7G database) 
We collected a total 69,159 internal m7G sites reported from eight exper-
iments in two independent studies (Malbec, et al., 2019; Zhang, et al., 
2019). The data were generated using three different techniques (m7G-
Seq, m7G-MeRIP-seq and m7G-miCLIP-Seq). In m7G-seq, a chemical 
reactivity can induce misincorporation at m7G sites during the process of 
reverse transcription, and all the known genomic mutation sites from 
dbSNP were excluded from the results to reveal m7G modification sites 
at base resolution. The same data processing protocol was implemented 
as the original publication (Zhang, et al., 2019) to reproduce the internal 
m7G map in HeLa and HepG2 cell lines, respectively, at base-resolution 
level. For m7G-MeRIP-Seq (Zhang, et al., 2019) and m7G-miCLIP-Seq, 
all the guanosines localized within the reported m7G peaks or clusters (of 
30bp window) were collected. It is worth mentioning that, as m7G-
MeRIP-Seq and m7G-miCLIP-Seq are not base-resolution approaches, 
the G sites extracted from the reported regions by the two techniques 
should still contain a large proportion of non-m7G sites. In m7GDB, the 
reliability of the m7G sites reported from these two techniques was fur-
ther assessed using our customized m7G site predictor m7GFinder (de-
tailed in the following). The datasets collected in m7GDB are summa-
rized in Table 1.  
 






































































69,159 record (44,058 unique sites) 
Note: m7GDB collected 44,058 unique internal mRNA m7G sites reported by three 
different sequencing approaches under eight experiment conditions. 
 
Internal small RNAs m7G sites collected in m7GDB (m7G da-
tabase) 
Besides the internal m7G sites on mRNAs, m7GDB also collected the 
known internal m7G sites on small RNAs (tRNA and rRNA) reported 
from m7G-MaP-Seq (Enroth, et al., 2019) and MODOMICS (Boccaletto, 
et al., 2018) (see Supplementary Table S1). 
 
Training and testing data for m7GFinder (m7G site predictor) 
We developed a customized predictor, m7GFinder, for internal m7G 
sites. The primary training and testing datasets were generated from the 
base-resolution m7G profiling technique m7G-Seq (Zhang, et al., 2019). 
Additionally, m7GFinder is validated on two independent techniques 
(m7G-MeRIP-Seq and m7G-miCLIP-Seq). For those m7G peaks identi-
fied by m7G-MeRIP-Seq (Zhang, et al., 2019), all the guanosines local-
ized within the reported peak ranges were considered as positive sites in 
the validation. For m7G-miCLIP-Seq (Malbec, et al., 2019), we retained 
only the guanosines located within both the reported 30bp flanking win-
dows and the claimed m7G motifs AACAAG (Malbec, et al., 2019) for 
performance validation of m7GFinder. To construct the m7G prediction 
model under the full transcript mode, the human m7G base-resolution 
sites from m7G-Seq were used as positive data, and the negative m7G 
sites were randomly collected from unmodified G sites located on the 
same transcripts as sites used as positive data. As the existing data over-
whelmingly relies on polyA selection, it cannot effectively capture in-
tronic RNA fragments and may lead to an over-estimation in the predic-
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tion accuracy under the full transcript mode, a mature mRNA mode was 
also considered as previously described (Chen, et al., 2019). Under the 
mature mRNA mode, the positive and negative m7G sites were filtered 
so that only those located on mature mRNAs remained (see Supplemen-
tary Fig. S1).  
It is worth noting that the full transcript and mature mRNA modes we 
considered here are different from those implemented in the SRAMP 
method (Zhou, et al., 2016). In the SRAMP method, the two models (full 
transcript and mature mRNA) describe whether predictive features 
should be extracted from pre-mRNA or mature mRNA; while in our 
method, the two models describe whether intronic sites were considered 
in the training and evaluation process. Due to the polyA selection step in 
RNA-seq library construction, intronic signals are likely to be under-
represented in experiment data, leading to an over-estimation in perfor-
mance evaluation under full transcript mode when intronic sites were 
considered; A mature mRNA mode is thus proposed for more accurate 
performance evaluation. 
For optimal use of the limited number of experimentally validated in-
ternal mRNA m7G sites, we collected 10 negative sites for each positive 
one, and the negative sites were randomly split into 10 subsets to gener-
ate 10 separate predictors each with 1:1 positive-to-negative ratio. The 
same procedure was also applied to generate negative sites for testing 
data, and the prediction results of the 10 predictors were averaged. For 
datasets generated from base-resolution technique (H1 and H2), dataset 
level cross-validation was performed, in which one of the datasets was 
used as training purpose, while the other one was used for independent 
testing. Furthermore, the H3-H8 datasets generated from m7G-MeRIP-
Seq and m7G-miCLIP-Seq were also used for performance validation. 
 
Predictive features of m7GFinder 
To achieve the best possible predictive performance, the m7G site predic-
tor we constructed considered both sequence and genome-derived fea-
tures as previously described in similar work (Chen, et al., 2019; Chen, 
et al., 2017). 
Sequence-derived features. The sequence-based features centered on 
m7G and non-m7G sites within the 41 bp flanking window were encoded 
by the chemical properties of nucleotides and nucleotide density. The 
chemical properties of the four types of nucleotides (A, G, C and U) 
were classified into three categories. The first category focused on the 
difference of the ring structure, in which adenosine and guanosine have 
two rings, while cytidine and uridine have one ring; In the second cate-
gory, hydrogen bonding is considered, in which guanosine and cytidine 
can form one more hydrogen bond than adenosine and uridine. In the last 
category, distinction is made in which adenosine and cytidine contain the 
amino group, whereas it is the keto group in the case of guanosine and 
uridine. To sum up, a vector ( , , )i i i iS x y z  can represent the i-th nu-
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(1) 
Therefore, the A, C, G, U can be encoded as a vector including three 
features (1,1,1), (0,1,0), (1,0,0) and (0,0,1), respectively. Additionally, 
the cumulative nucleotide frequency of nucleotide in the i-th position is 
calculated for the nucleotide density. To define the density of nucleotide 
in i - th position, the formula /i id A i  is introduced as the sum of the 
occurrences of the nucleotide 
iA  before the 1i  position divided by its 
position i . If we use a sample sequence ‘CGGAUAC’ to explain the 
formula, the cumulative frequency for adenosine at the fourth and sixth 
position is calculated as 0.25 (1/4) and 0.33 (2/6), respectively; similarly, 
the frequency for cytidine is 1 (1/1) and 0.29 (2/7) at the first and sev-
enth position of the sample sequence. 
Genome-derived features. Besides the conventional sequence-derived 
features mentioned above, we also integrated 42 additional genome-
derived features (Supplementary Table S2) into our m7G site prediction 
model that may contribute to the prediction accuracy, including 35 fea-
tures considered previously (Chen, et al., 2019) and 7 new features. 
Specifically, we first paid attention to the transcript regions within which 
the guanosine falls: this information was represented by the Genomic 
Features 1-16 as dummy variable features, as generated by the Ge-
nomicFeatures R/Bioconductor package using the transcript annotations 
hg19 TxDb package (Lawrence, et al., 2013). We only extracted the 
transcript sub-regions on the primary (longest) transcripts of each gene, 
helping to eliminate isoform ambiguity from our analysis. For Genomic 
Features 17-20, we considered the relative position of the transcript 
regions (3’UTR, 5’UTR, CDS, and whole transcript) as encoded by a 
real value, such as the distance from the guanosine to the 3’ end divided 
by the width of the region. If a site does not belong to one specific re-
gion, the value is set to zero. The length of the transcript region where 
m7G modification sites fall was represented by Genomic Features 21-25. 
For Genomic Features 26-27, the distance from the guanosine sites to the 
5’ end or 3’ end of the splicing junctions is considered. The Phast-Cons 
(Siepel, et al., 2005) score and the fitness consequence (Gulko, et al., 
2015) scores are used to measure the conservation degree, which are 
shown in features 28-31 calculated for the guanosine sites and its flank-
ing regions. The RNA secondary structures around the guanosine site are 
predicted using RNAfold from the Vienna RNA package (Lorenz, et al., 
2011) and shown in features 32-33. Genomic properties of transcripts 
where m7G sites are located were represented in features 34-38. Last but 
not least, the attributes of genes or transcripts were represented in fea-
tures 39-42, such as microRNA targeted genes (Chou, et al., 2017) and 
HNRNPC binding sites (2012). Please refer to Supplementary Table S2 
for the details of all the 42 genomic features considered in m7GFinder.  
 
Machine learning approach and performance evaluation of 
m7GFinder 
SVM (Support Vector Machine) has been shown to be a quite effective 
machine learning algorithm in the field of computation biology and 
achieved good performance previously in prediction of m6A RNA meth-
ylation sites (Chen, et al., 2017). We applied the R language interface of 
LIBSVM (Chang and Lin, 2011) to construct our m7G site prediction 
model, and the radial basis function was set as kernel following the de-
fault setting for other parameters. A 5-fold cross-validation was per-
formed on training dataset, and the final performance of the m7GFinder 
was evaluated by independent testing datasets including those generated 
from the same or different techniques, as described previously. The 
prediction accuracy was represented by the ROC (receiver operating 
characteristic curve) (sensitivity against 1-specificity), and the area under 
ROC curve (AUROC) was calculated as the main performance evalua-
tion metric. Only the m7G sites not previously applied to training data 
were considered in the performance testing, so that the performance 
directly reflects the capability of our approach in discovering less promi-
nent (or condition-specific) previously unknown m7G sites, rather than 
well-established (or house-keeping) internal m7G sites that are robustly 
detected in different m7G profiling experiments, as previously imple-
mented (Chen, et al., 2019). 
When comparing the performances of m7GFinder and a previous de-
veloped m7G site predictor iRNA-m7G, since the iRNA-m7G web server 
reports only the putative m7G sites with scores above its cutoff level, we 
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cannot calculate the area under ROC curve (AUROC) as previously; 
instead, the sensitivity (Sn), specificity (Sp), accuracy (ACC), and Mat-
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where TP represents the true positive, while TN represents the true 
negative; FP is the number of false positive, and FN the number of false 
negative. 
 
Output of m7GFinder 
To convey whether a guanosine site is more likely to be an m7G RNA 
methylation site or not, the likelihood ratio (LR) is calculated as the 
formula below, and reported in m7GFinder as its output: 
  
(6) 
A larger LR value means that the site is more likely to be an m7G 
RNA methylation site. The upper bound of a p-value can be inferred 
from the LRs of all the transcriptome G sites. It suggests how extreme is 
the observed LR among all the transcriptome G sites, and can be used to 
assess the statistical significance of a LR value. This is also reported by 
m7GFinder. 
 
Annotation of post-transcriptional regulations affected by 
internal mRNA m7G 
To unveil the potential impact of m7G in post-transcriptional regulations, 
we found the intersection of all the internal m7G sites with RBP regions 
and miRNA targets. Notably, although the binding information of 
METTL1, a known m7G methyltransferase, is not available from existing 
RBP database. This information has been manually added to m7GHub 
(Bao, et al., 2018). Furthermore, we obtained the regions of splicing sites 
within 100 bp upstream and downstream, the m7G sites localized on this 
regions were also collected for analysis. These functional annotations are 
available in both m7GDB and m7GFinder (when the inputs are genome 
coordinates). 
 
Assessment of the impact of genetic mutations on internal 
mRNA m7G methylation status by m7GSNPer 
The web server m7GSNPer was designed to evaluate the epitranscrip-
tome impact of genetic mutations on internal m7G RNA methylation 
status. A variant is defined as m7G-associated variant if it can cause the 
alteration of methylation status of an internal mRNA m7G site, including 
two scenarios: (1) a mutation directly alters G to another base, leading to 
the loss of an experimentally validated or computationally predicted m7G 
site, or alters another nucleotide to G, leading to the gain of a computa-
tionally predicted m7G site; (2) a mutation alters the nucleotide within 
the 41 bp flanking window of an experimentally validated or computa-
tionally predicted m7G site, causing significant increase or decrease in 
the probability of m7G methylation, as is reported by our customized 
m7G site predictor m7GFinder.  
The m7G sites considered in m7GSNPer were classified into three 
confidence levels. The high confidence level involves experimentally 
validated m7G sites reported by base-resolution sequencing approach 
m7G-seq. The medium level involves m7G sites identified from non-
base-resolution approaches (m7G-MeRIP-Seq and m7G-miCLIP-Seq). In 
addition, m7GFinder was applied transcriptome-wide to identify all the 
putative m7G sites, which are defined as m7G sites of low confidence 
level. The complete dataset of 37,094,832 germline variants (dbSNP151) 
from dbSNP (Sherry, et al., 2001) and 3,820,716 somatic variants 
(TCGA v15.0) from TCGA (Tomczak, et al., 2015) were collected as 
inputs to decipher the applications of m7GSNP. Only the variants local-
ized on exons were considered in the analysis.  
 
Association analysis between m7G and various diseases 
(m7GDiseaseDB) 
The m7GDiseaseDB was developed to explore the potential association 
between m7G sites and disease-associated genetic mutations, which 
might implicate possible disease pathogenesis involving m7G RNA 
methylation. In this analysis, the disease-associated variants act as a 
potential bridge to link m7G RNA modification to known diseases. In 
order to unveil the potential impact of m7G modification on diseases, 
disease-associated SNPs (tagSNPs) were derived from different re-
sources, including GWAS catalog (Buniello, et al., 2018), Johnson and 
O’Donnel (Johnson and O'Donnell, 2009) and ClinVar (Landrum, et al., 
2015), we then mapped all m7G-associated variants to the collected 
tagSNPs. To annotate m7G sites and m7G-associated variants, the tran-
script structure from UCSC (Lawrence, et al., 2013) was used, and the 
evolutionary conservation of sequence was extracted from phastCons 20-
way (Siepel, et al., 2005). In addition, the deleterious level of each m7G-
SNPs was analyzed by SIFT (Kumar, et al., 2009), PolyPhen2 HVAR 
(Adzhubei, et al., 2010), PolyPhen2HDIV (Adzhubei, et al., 2010), LRT 
(Chun and Fay, 2009) and FATHMM (Shihab, et al., 2013) using 
ANNOVAR package (Wang, et al., 2010).  
 
Website construction 
MySQL tables were exploited for the storage and management of the 
metadata in m7GHub. Hyper Text Markup Language (HTML), Cascad-
ing Style Sheets (CSS) and Hypertext Preprocessor (PHP) were used to 
construct the web interface. The multiple statistical diagrams were pre-
sented by EChars, and Jbrowse genome browser (Skinner, et al., 2009) 
was employed for interactive exploration and visualization of relevant 
genome coordinate-based records. 
3 Results 
Collection of internal mRNA m7G sites in m7GDB 
A total of 44,058 internal m7G sites were collected from data generated 
under eight samples profiled with three different techniques in two inde-
pendent studies (see Table 1). These sites were annotated with post-
transcriptional regulations such as miRNA target sites, alternative splic-
ing sites and RNA binding protein target sites, which may be potentially 
regulated by internal mRNA m7G methylation. The reliability of internal 
m7G sites extracted from non-base-resolution techniques was also re-
evaluated using our customized m7G predictor m7GFinder. To the best 
of our knowledge, m7GDB is the first and only database for internal 
mRNA m7G sites. Besides, m7GDB also collected internal m7G sites 
detected in small RNAs, i.e., tRNA and rRNA, as well as the m7G sites 
collected in MODOMICS database (see Supplementary Table S1), 
ACC 
TP TN
TP TN  FP  FN
LR 
P (observation | m7G)
P (observation | G)
m7GHub 
making m7GDB the most comprehensive collection of internal RNA 
m7G sites. 
3.1 Feature selection, and performance evaluation of 
m7GFinder 
For m7G site prediction, both full transcript mode and mature mRNA 
mode were constructed. The m7G-Seq introduced by Zhang et al. (Zhang, 
et al., 2019) performed polyA selection in the step of RNA-seq library 
preparation. Therefore, the mature mRNA mode was considered to re-
duce the potential over-estimation of accuracy. Feature selection was 
implemented to identify the most important subset of genomic features, 
which in return avoids the over-fitting issue. We implemented the Per-
turb method (Gevrey, et al., 2003) to evaluate the relative importance of 
each genomic feature under the two modes. The ranking of each ge-
nome-derived feature can be found in Supplementary Fig. S2. To 
achieve the most robust performance, we used the top 19 genomic fea-
tures to construct the predictor under full transcript mode, and the top 22 
for mature mRNA mode. 
 


















m7GFinder 0.977 0.976 0.977 
PseKNC2  0.750 0.721 0.736 
EIIP 0.786 0.785 0.786 
PSNP 0.844 0.837 0.841 
Composition 0.785 0.783 0.784 
MethyRNA 0.824 0.772 0.798 




m7GFinder 0.973 0.974 0.974 
PseKNC2 0.697 0.705 0.701 
EIIP 0.737 0.783 0.760 
PSNP 0.808 0.811 0.810 
Composition 0.737 0.781 0.759 
MethyRNA 0.728 0.759 0.744 





m7GFinder 0.903 0.891 0.897 
PseKNC2 0.673 0.647 0.660 
EIIP 0.717 0.709 0.713 
PSNP 0.788 0.785 0.787 
Composition 0.717 0.708 0.713 
MethyRNA 0.753 0.724 0.739 




m7GFinder 0.904 0.874 0.889 
PseKNC2 0.591 0.577 0.584 
EIIP 0.651 0.614 0.633 
PSNP 0.688 0.649 0.669 
Composition 0.649 0.613 0.631 
MethyRNA 0.730 0.718 0.724 
AutoCorrelation 0.520 0.511 0.516 
Note: 93.9% of m7G sites reported by m7G-Seq can be identified by m7GFinder 
under full transcript mode (sensitivity: 0.939) at the cut-off of 0.5 in prediction 
probability. 
 
The performance of the newly constructed m7G site predictor 
(m7GFinder) was evaluated by 5-fold cross validation, independent 
testing, and compared with other sequence-derived encoding methods, 
including PseKNC2 (Liu, et al., 2015; Liu, et al., 2015), EIIP (He, et al., 
2018; He, et al., 2019), PSNP (He, et al., 2018; He, et al., 2019), Compo-
sition (Zhou, et al., 2016),  MethyRNA (Chen, et al., 2017) and Auto-
Correlation (Liu, et al., 2015; Liu, et al., 2015) (see Table 2). When 
testing on independent datasets generated from two cell lines, 
m7GFinder achieved an average AUROC of 0.974 and 0.889 under full 
transcript and mature mRNA modes, respectively, which was superior to 
the other sequence encoding schemes as well as the newly developed 
iRNA-m7G method (AUROC of 0.946 under full transcript mode) 
(Chen, et al., 2019).  
It was shown previously that technological preference may signifi-
cantly affect the results of epitranscriptome profiling (Adachi, et al., 
2018; Hussain, et al., 2013; Zaringhalam and Papavasiliou, 2016). As 
m7GFinder was trained on base-resolution m7G-seq data, and the per-
formance can be significantly over-estimated under the full transcript 
mode, we further validated its performance on datasets generated from 
two other m7G profiling techniques (m7G-MeRIP-Seq and m7G-miCLIP-
Seq) under mature mRNA mode. Consistent with previous results, the 
newly developed m7GFinder approach substantially outperformed other 
encoding schemes (Supplementary Table S3) on datasets generated by 
both m7G-MeRIP-Seq and m7G-miCLIP-Seq techniques, with AUROC 
= 0.753 and 0.855, respectively. Taken together, these results suggest 
that m7GFinder should be a reliable tool for identifying putative internal 
mRNA m7G sites. It is worth noting that, although different overall pat-
terns of internal mRNA m7G sites were reported previously in m7G-
miCLIP-Seq (showing enrichment of internal mRNA m7G in 5’UTRs) 
and m7G-seq (showing enrichment of m7G in 3’UTRs) (Malbec, et al., 
2019; Zhang, et al., 2019), the prediction results of m7G-seq-trained 
predictor agreed well with the m7G-miCLIP-Seq data (AUROC = 0.855), 
suggesting that the positive sites captured by the two techniques share 
something significant in common, and that these features were success-
fully captured by our predictor m7GFinder. Meanwhile, as explained 
previously, m7G-MeRIP-Seq is not a base-resolution technique, and 
there exist a large number of unmodified G sites under the m7G peaks 
called from m7G-MeRIP-Seq data; nevertheless, the results of 
m7GFinder  and m7G-MeRIP-Seq data were coherent (AUROC = 
0.753), suggesting consistent patterns were captured among them. 
In addition, we further compared the performance of m7GFinder with 
iRNA-m7G, which, to our knowledge, is so far the only computational 
model published for internal mRNA m7G site prediction. As the area 
under ROC curve (AUROC) cannot be calculated from the output of the 
iRNA-m7G web server of, we instead calculated the sensitivity (Sn), 
specificity (Sp), accuracy (ACC), and Matthews correlation coefficient 
(MCC) for performance evaluation. Meanwhile, since the training data 
used for iRNA-m7G was generated from m7G-seq, to avoid overfitting, 
we applied the dataset from another technique m7G-miCLIP-seq for an 
independent testing. As is shown in Table 3, our newly proposed model 
m7GFinder obtained the highest accuracy of 0.760, which is approxi-
mately 9.3% higher than that of iRNA-m7G method.  
The performance evaluation of predictor on the binding regions of en-
zymes related to m6A RNA modification have been applied in previously 
study (Zhou, et al., 2016). In our study, we also tested whether the newly 
purposed approach can predict the binding sites of METTL1, which is a 
known m7G methyltransferase. The motifs inside the experimentally 
identified METTL1 binding regions (Bao, et al., 2018) were used as the 
positive data. While the negative sites were randomly selected outside 
the METTL1 binding region, keeping the 1:10 positive-to-negative ratio. 
Consistent with previous results, m7GFinder substantially outperformed 
other encoding schemes under mature mRNA model (see Supplemen-
tary Table S4), suggesting again the reliability of our method from a 
B.Song et al. 
different perspective. Besides, the comparison between different algo-
rithms indicated that SVM (Support Vector Machine) was a quite effec-
tive machine learning approach and achieved the best performance in our 
study. 
 
Table 3. Performance comparison of different methods tested on inde-





Sn Sp ACC MCC 
m7GFinder 0.842 0.710 0.760 0.536 
iRNA-m7G 0.866 0.469 0.667 0.364 
PseKNC2 0.571 0.564 0.567 0.134 
EIIP 0.634 0.620 0.626 0.253 
PSNP 0.688 0.790 0.728 0.467 
Composition 0.635 0.622 0.628 0.257 
MethyRNA 0.684 0.664 0.673 0.347 
AutoCorrelation 0.553 0.556 0.554 0.108 
3.2 Assessing the impact of mutations on internal m7G 
methylation (m7GSNPer) 
The m7GSNPer web server was developed to evaluate the impact of 
genetic variants on internal m7G RNA methylation based on both our 
customized high-accuracy m7G site predictor (m7GFinder) and the col-
lection of experimentally validated internal mRNA m7G sites. It critical-
ly assesses the changes (in the probability) of m7G methylation induced 
by an arbitrary genetic mutation, unraveling the potential functional 
machinery of the mutation via the epitranscriptome regulation. The 
m7GSNPer server also systemically annotates the m7G-associated vari-
ants with disease analysis and various post-transcriptional regulations as 
with m7GDB. To our knowledge, it is the first of its kind developed for 
assessing the impact of mutations on internal m7G RNA modification. 
3.3 Comparing the m7G and non-m7G associated variants 
(m7GDiseaseDB) 
With m7GSNPer, we systematically evaluated the potential relationship 
between the methylation status of internal mRNA m7G sites and all the 
known genetic variants around it. In total, we found 57,769 m7G-
associated SNPs, which may cause the gain or loss of an m7G site in 
human (see Supplementary Table S5). A total of 735 and 12,800 genet-
ic variants may cause the loss of an experimentally validated m7G site at 
high and medium confidence level, respectively. We observed that the 
m7G-associated SNPs were enriched in coding DNA sequence (a total of 
50,970 m7G-associated SNPs, 90.54%), and especially for the predicted 
level (40,275 SNPs, 92.75%). The distribution characteristics of m7G-
associated SNPs and non-m7G SNPs in different transcript structures 
were summarized in Supplementary Table S6. We then asked that if 
m7G-associated variants differ from those non-m7G-associated variants 
(non-m7G variants) in some biological meaning ways. PhastCons score 
was considered to evaluate the conservation degree between the two 
categories of variants. We found that the m7G-associated variants were 
more conserved than non-m7G variants (see Fig. 1A), suggesting that the 
sites where m7G-associated variants localized may undergo stronger 
selection pressure than that of non-m7G variants, and the genetic muta-
tions on those more conservative sites may relate to relatively more 
important biological functions (e.g., the change of m7G methylation). 
Besides, the m7G-associated variants were predicted to have a higher 
proportion in both high-deleterious (14,589 variants, 25.56%; P < 0.001, 
Chi-squared test) and medium-deleterious (13,615 variants, 23.85%; P < 
0.001, Chi-squared test) levels, compared with non-m7G variants (Fig. 
1B). Moreover, the proportion of nonsynonymous variants in m7G-
associated SNPs is higher than non-m7G SNPs (Fig. 1C, P < 0.001, 2-
tailed population test), revealing the variants that affect m7G methylation 
were also more likely to alter the amino acids in a protein sequence. We 
also observed that m7G-associated SNPs occurred more frequently in 
binding regions of METTL1 than the non-m7G SNPs with a p-value 
smaller than 0.001 (Supplementary Fig. S3). To sum up, these results 
suggested that the m7G-associated variants can be distinguished from the 
majority of passenger variants, and may have important roles in human 
genomes. 
Fig. 1. The comparison between m7G-associated variants and non-m7G-associated 
variants. A) The cumulative distribution function of differences between phastCons score 
of m7G-associated variants and non-m7G variants, m7G-associated variants were more 
conservative than non-m7G variants. B) Proportional distribution of the m7G-associated 
variants and non-m7G variants at high, medium, and low deleterious levels. The deleteri-
ous level was analyzed by SIFT (Kumar, et al., 2009), PolyPhen2 HVAR (Adzhubei, et 
al., 2010), PolyPhen2HDIV (Adzhubei, et al., 2010), LRT (Chun and Fay, 2009) and 
FATHMM (Shihab, et al., 2013), a high level indicated that the variant was considered 
deleterious in at least 3 out of the 5 above-listed methods. C) Proportional distribution of 
the m7G-associated variants and non-m7G variants at different variant types, nonsynony-
mous type constitutes the majority of the m7G-associates variants. 
3.4 Association of disease and internal mRNA m7G sites 
(m7GDiseaseDB) 
The identified m7G-associated variants were also annotated with disease 
information and various post-transcriptional regulations (see Supple-
mentary Table S7). For RBP binding regions, 6,863 and 22,078 m7G-
associated variants from dbSNP and TCGA are related to 166 and 170 
RBPs. For disease association analysis, 1,218 m7G variants localized on 
716 genes were found to be associated with 681 diseases, which high-
lights the potential pathogenic role of the disease-related genetic muta-
tions via the regulation of internal m7G RNA methylation functioning at 
the epitranscriptome layer.  
We then identified the disease phenotypes that are most enriched with 
m7G variants. Among them, 33 variants (2.71%) were related to heredi-
tary cancer-predisposing syndrome (ClinVar study, Accession: 
RCV000130572.2), followed by 16 variants (1.31%) relate to cardiovas-
cular phenotype and 16 variants (1.31%) in primary ciliary dyskinesia 
(see Table 4).  
In the previous disease-relevant studies, synonymous variants were of-
ten being neglected by their property of not altering the amino acids 
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tion. In summary, m7GHub 
(www.xjtlu.edu.cn/biologicalsciences/m7ghub) will serve as a useful 
resource for studies of the internal mRNA m7G modification in human.  
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